Teladoc Health announces acquisition of France-based MedecinDirect
Category: #health  By Pankaj Singh  Date: 2019-03-20
  • share
  • Twitter
  • Facebook
  • LinkedIn

Teladoc Health announces acquisition of France-based MedecinDirect
  • The deal is expected to be closed in first half of this year
     
  • Financial terms of the deal were not disclosed yet

Virtual care provider Teladoc Health has announced that it has acquired France-based telemedicine provider MédecinDirect to expand its international business. Teladoc will combine its virtual care services with strong and established local medical operations of MédecinDirect and hopes to benefit more people across France by providing virtual care services, as Teladoc is already stable to capitalize on favorable market conditions.

This deal is expected to be closed in first half of this year, but financial terms of the deal were not disclosed yet. It is stated that acquisition will be immaterial to the financial results of Teladoc Health.

MédecinDirect will become the French country unit of Teladoc Health with existing operations in United Kingdom, Australia, Portugal, Chile, Brazil, Spain, Hungary, China and Canada.

As reported by Teladoc, France has increasing demands for accessible high-quality healthcare services like other countries around the world. Consumers are being more aware about virtual care and the recent regulatory changes have been positive about virtual care reimbursement. This has ripened the market to adopt virtual care. MédecinDirect has well-established client base in France and partnership with almost half of the 30 private medical insurers (PMIs) and more than 40 leading insurance companies.

Francois Lescure, CEO and co-founder, MédecinDirect, reportedly stated that they have enjoyed success in virtual care market and after acquisition with Teladoc Health they are expecting to reach more people and offer more care needs to improve healthcare across the country. With Teladoc Health, MédecinDirect has plans of transforming healthcare accessibility, Lescure further added.

Carlos Nueno, President of Teladoc Health International, noted that the company has a vision of global expansion and with focus on this, Teladoc will become leader in France’s healthcare market and will immediately impact delivery of healthcare in France. He added that Teladoc will bring full suite of virtual care services with support of strong base achieved by MédecinDirect, to multinational clients who have been willing to expand.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

vTv Therapeutics unveils additional positive data from diabetic study
vTv Therapeutics unveils additional positive data from diabetic study
By Pankaj Singh

TTP399 increased Time in Range, reduced hyperglycemia time, a bolus insulin dose that was lower and fewer hypoglycemic events.   TTP399 could be placed for Phase 3 development to address Type 1 Diabetes. vTv Therapeutics Inc., a biopharmac...

Westlake to advise Frontier Energy on its takeover of Energy Insight
Westlake to advise Frontier Energy on its takeover of Energy Insight
By Pankaj Singh

Energy efficiency is becoming a point of focus for several companies operating across the world. Various firms worldwide are turning towards energy efficiency consulting companies to efficiently manage the energy they use. This not only saves energy ...

Rocket Pharma unveils Phase 1/2 trial data for its Fanconi Anemia drug
Rocket Pharma unveils Phase 1/2 trial data for its Fanconi Anemia drug
By Pankaj Singh

The manuscript includes data of the first four trial participants that were treated with RP-L102 under the Phase 1/2 FANCOLEN-I study.   First RP-L102 trail data demonstrates increase in bone marrow engraftment levels, which further leads to...